The role of TGF-β in growth, differentiation, and maturation of B lymphocytes

Microbes and Infection

Volumn 1, Issue 15, 1999, Pages 1297-1304

  Lebman, Deborah A ^a   Edmiston, Jeffery S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Apoptosis; B cell maturation; IgA; Isotype switching; Lymphopoiesis; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CYTOKINE PRODUCTION; GENE SWITCHING; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0033378589     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00254-3     Document Type: Review

References (64)

1. Lee G., Ellingsworth L.R., Gillis S., Wall R., Kincade P.W. Beta transforming growth factors are potential regulators of B lymphoiesis. J. Exp. M. 166:1987;1290-1300.
2. Tang J., Nuccie B.L., Ritterman I., Liesveld J.L., Abboud C.N., Ryan D.H. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J. Immunol. 159:1997;117-125.
3. Rehmann J.A., Lebien T.W. Transforming growth factor-beta regulates normal human pre-B cell differentiation. Int. Immunol. 6:1994;315-6322.
4. Kehrl J.H., Roberts A.B., Wakefield L.M., Jakowlew S., Sporn M.B., Fauci A.S. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:1986;3855-3860.
5. Petit-Koskas E., Genot E., Lawrence D., Kolb J.P. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta. Eur. J. Immunol. 18:1988;111-116.
6. Armitage R.J., Macduff B.M., Spriggs M.K., Fanslow W.C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150:1993;3671-3680.
7. Bouchard C., Fridman W.H., Sautes C. Mechanism of inhibition of lipopolysaccharide-stimulated mouse B-cell responses by transforming growth factor-beta 1. Immunol. Lett. 40:1994;105-110.
8. Smeland E.B., Blomhoff H.K., Holte H., Ruud E., Beiske K., Funderud S., Godal T., Ohlsson R. Transforming growth factor type β (TGF β) inhibits G1 to S transition but not activation of human B lymphocytes. Exp. Cell Res. 171:1987;213-222.
9. Altiok A., Bejarano M.T., Klein G., Klein E. Effect of TGF-beta 1 on the EBV-induced transformation of human lymphocyte cultures. Int. J. Cancer. 50:1992;772-776.
10. Altiok A., Ehlin-Henriksson B., Klein E. Correlation between the growth-inhibitory effect of TGF-beta 1 and phenotypic characteristics in a panel of B-cell lines. Int. J. Cancer. 55:1993;137-140.
11. Altiok A., DiRenzo L., Altiok E. Influence of transforming growth factor-beta (TGF-β) on the immunoglobulin production by EBV-infected B cell cultures. Immunol. Lett. 43:1994;199-202.
12. Babcock G.J., Decker L.L., Volk M., Thorley-Lawson D.A. EBV persistence in memory B cells in vivo. Immunity. 9:1998;395-404.
13. Holder M.J., Knox K., Gordon J. Factors modifying survival pathways of germinal center B cells, Glucocorticoids and transforming growth factor-beta but not cyclosporin A or anti-CD19 block surface immunoglobulin-mediated rescue from apoptosis. Eur. J. Immunol. 22:1992;2725-2728.
14. Lomo J., Blomhoff H.K., Beiske K., Stokke T., Smeland E.B. TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol. 154:1995;1634-1643.
15. Fischer G., Kent S.C., Joseph L., Green D.R., Scott D.W. Lymphoma models for B cell activation and tolerance, X, Anti-mu- mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc. J. Exp. M. 179:1994;221-228.
16. Arsura M., Wu M., Sonenshein G.E. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells transcriptional activation of I kappa B alpha. Immunity. 5:1996;31-40.
17. Coffey R.J.J., Bascom C.C., Sipes N.J., Graves-Deal R., Weissman B.E., Moses H.L. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol. Cell Biol. 8:1988;3088-3093.
18. Pietenpol J.A., Holt J.T., Stein R.W., Moses H.L. Transforming growth factor beta 1 suppression of c-myc gene transcription role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA. 87:1990;3758-3762.
19. Brown T.L., Patil S., Basnett R.K., Howe P.H. Caspase inhibitor BD-fmk distinguishes transforming growth factor beta- induced apoptosis from growth inhibition. Cell Growth Differ. 9:1998;869-875.
20. Saltzman A., Munro R., Searfoss G., Franks C., Jaye M., Ivashchenko Y. Transforming growth factor-beta-mediated apoptosis in the Ramos B- lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Exp. Cell Res. 242:1998;244-254.
21. Coffman R.L., Lebman D.A., Shrader B. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. M. 170:1989;1039-1044.
22. Sonoda E., Matsumot R., Hitoshi E., Ishii T., Sugimoto M., Araki S., Toninaga A., Yamaguchi N., Takatsu K. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. M. 170:1989;1415-1420.
23. Lebman D.A., Lee F.D., Coffman R.L. Mechanism for transforming growth factor β and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J. Immunol. 144:1990;952-959.
24. Lebman D.A., Griffin P.M., Cebra J.J. Relationship between expression of IgA by Peyer's patch cells and functional IgA memory cells. J. Exp. M. 166:1987;1405-1418.
25. Kim P.H., Kagnoff M.F. Transforming growth factor β1 increases IgA isotype switching at the clonal level. J. Immunol. 145:1990;3773-3778.
26. Lutzker S., Alt F.W. Structure and expression of germ line immunoglobulin2b transcripts. Mol. Cell. Biol. 8:1988;1849-1852.
27. Stavnezer J., Radcliffe Y.C., Lin Y.C., Nietupski J., Berggren L., Sitia R., Severinson E. Immunoglobulin heavy chain switching may be directed by prior induction of transcripts from constant region genes. Proc. Natl. Acad. Sci. USA. 85:1988;7704-7708.
28. Coffman R.L., Lebman D.A., Rothman P. The mechanism and regulation of immunoglobulin isotype switching. Dixon F.J. Advances in Immunology. 1994;229-270 Academic Press, San Diego.
29. Lebman D.A., Nomura D.Y., Coffman R.L., Lee F.D. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type β induced isotype switching. Proc. Natl. Acad. Sci. USA. 87:1990;3962-3966.
30. Matsuoka M., Yoshida K., Maeda T., Usuda S., Sakano H. Switch circular DNA formed in cytokine-treated mouse splenocytes evidence for intramolecular DNA deletion in immunoglobulin class switching. Cell. 62:1990;135-142.
31. Iwasato T., Arakawa H., Shimizu A., Honjo T., Yamagishi H. Biased distribution of recombination sites within S regions upon immunoglobulin class switch recombination induced by transforming growth factor β and lipopolysaccharide. J. Exp. M. 175:1992;1539-1546.
32. + B cells regardless of the method of B cell activation. J. Immunol. 148:1992;3830-3836.
33. Lebman D.A., Coffman R.L. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J. Exp. M. 168:1988;853-862.
34. Kim P.H., Kagnoff M.F. Transforming growth factor β1 is a costimulator for IgA production. J. Immunol. 144:1990;3411-3416.
35. McIntyre T.M., Kehry M.R., Snapper C.M. Novel in vitro model for high-rate IgA class switching. J. Immunol. 154:1995;3156-3161.
36. Lebman D.A., Park M.J., Hansen-Bundy S., Pandya A. Mechanism for transforming growth factor β regulation of α mRNA in lipopolysaccharide-stimulated B cells. Int. Immunol. 6:1994;113-119.
37. Edmiston J.S., Lebman D.A. A transforming growth factor-beta regulable RNA-binding protein interacts specifically with germline immunoglobulin alpha transcripts. Int. Immunol. 9:1997;427-433.
38. Shockett P., Stavnezer J. Effect of cytokines on switching to IgA and α germline transcripts in the B lymphoma I, 29μ Transforming growth factor-β activates transcription of the unrearranged Ca gene. J. Immunol. 147:1991;4374-4383.
39. Stavnezer J. Regulation of antibody production and class switching by TGF-β J. Immunol. 155:1995;1647-1651.
40. Lin Y.-C.A., Stavnezer J. Regulation of transcription of the germ-line Igalpha constant region gene by an ATF element and by novel transforming growth factor beta1 responsive elements. J. Immunol. 149:1992;2914-2925.
41. Shi M.J., Stavnezer J. CBF alpha3 (AML2) is induced by TGF-beta1 to bind and activate the mouse germline Ig alpha promoter. J. Immunol. 161:1998;6751-6760.
42. Whitmore A.C., Prowse D.M., Haughton G., Arnold L.W. Ig isotype switching in B lymphocytes, The effect of T cell- derived interleukins cytokines cholera toxin antigen on isotype switch frequency of a cloned B cell lymphoma. Int. Immunol. 3:1991;95-103.
43. Islam K.B., Nilsson L., Sideras P., Hammarstrom L., Edvard Smith C.I. TGF β1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int. Immunol. 3:1991;1099-1106.
44. Nilsson L., Islam K.B., Olafsson O., Zalcberg I., Samakovlis C., Hammarstrom L., EdvardSmith C.I., Sideras P. Structure of TGF-β1 induced human immunoglobulin Cα1 and Cα2 germ-line transcripts. Int. Immunol. 3:1991;1107-1115.
45. Defrance T., Vanbervliet B., Briere F., Durand I., Rousset F., Banchereau J. Interleukin 10 and Transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cell to secrete immunoglobulin A. J. Exp. M. 175:1992;671-682.
46. Van Vlasselaer P., Punnonen J., DeVries J.E. Transforming growth factor-beta directs IgA switching in human B cells. J. Immunol. 148:1992;2062-2067.
47. Kitani A., Strober W. Differential regulation of C alpha 1 and C alpha 2 germ-line and mature mRNA transcripts in human peripheral blood B cells. J. Immunol. 153:1994;1466-1477.
48. Zan H., Cerutti A., Dramitinos P., Schaffer A., Casali P. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta evidence for TGF-beta but not IL-10-dependent direct Smu - >Salpha and sequential Smu - >Sgamma Sgamma- ->Salpha DNA recombination. J. Immunol. 161:1998;5217-5225.
49. + B cell line. J. Immunol. 160:1998;2145-2157. 9.
50. Schaffer F.M., Monteiro R.C., Volanakis J.E., Cooper M.D. IgA deficiency. Immunodefic. Rev. 3:1991;15-44.
51. Schaffer F.M., Palermos J., Zhu Z.B., Barger B.O., Cooper M.D., Volanakis J.E. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc. Natl. Acad. Sci. USA. 86:1989;8015-8019.
52. Briere F., Bridon J.M., Chevet D., Souillet G., Bienvenu F., Guret C., Martinez-Valdez H., Banchereau J. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J. Clin. Invest. 94:1994;97-104.
53. Islam K.B., Baskin B., Nilsson L., Hammarström L., Sideras P., Smith C.I.E. Molecular analysis of IgA deficiency Evidence for impaired switching to IgA. J. Immunol. 152:1994;1442-1452.
54. Muller F., Aukrust P., Nilssen D.E., Froland S.S. Reduced serum level of transforming growth factor-beta in patients with IgA deficiency. Clin. Immunol. Immunopathol. 76:1995;203-208.
55. Baskin B., Pettersson E., Rekola S., Smith C.I., Islam K.B. Studies of the molecular basis of IgA production subclass regulation and class-switch recombination in IgA nephropathy patients. Clin. Exp. Immunol. 106:1996;509-517.
56. Lai K.N., Ho R.T., Leung J.C., Chui Y.L., Lim P.L., Lui S.F., Li P.K. CD4-positive cells from patients with IgA nephropathy demonstrate increased mRNA of cytokines that induce the IgA switch and differentiation. J. Pathol. 174:1994;13-22.
57. McIntyre T.M., Klinman D.R., Rothman P., Lugo M., Dasch J.R., Mond J.J., Snapper C.M. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J. Exp. M. 177:1993;1031-1037.
58. Kehrl J.H., Thevenin D., Rieckmann P., Fauci A.S. Transforming growth factor-B suppresses human lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J. Immunol. 146:1991;4016-4023.
59. Lamson G., Koshland M.E. Changes in J chain and mu chain RNA expression as a function of B cell differentiation. J. Exp. M. 160:1984;877-892.
60. Early P., Rogers J., Davis M., Calame K., Bond M., Wall R., Hood L. Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell. 20:1980;313-319.
61. Lebman D.A., Park M.J., Fatica R., Zhang Z. Regulation of usage of membrane and secreted 3' termini of α mRNA differs from μ mRNA. J. Immunol. 148:1992;3282-3289.
62. Takagaki Y., Seipelt R.L., Peterson M.L., Manley J.L. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell. 87:1996;941-952.
63. Martincic K., Campbell R., Edwalds-Gilbert G., Souan L., Lotze M.T., Milcarek C. Increase in the 64-kDa subunit of the polyadenylation/cleavage stimulatory factor during the G0 to S phase transition. Proc. Natl. Acad. Sci. USA. 95:1998;11095-11100.
64. Snapper C.M., Waegell W., Beernink H., Dasch J.R. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J. Immunol. 151:1993;4625-4636.